Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Variants of Rab GTPase-Effector Binding Protein-2 Cause Variation in the Collateral Circulation and Severity of Stroke.

Lucitti JL, Sealock R, Buckley BK, Zhang H, Xiao L, Dudley AC, Faber JE.

Stroke. 2016 Dec;47(12):3022-3031. Epub 2016 Nov 3.

PMID:
27811335
2.

Fine-tuning vascular fate during endothelial-mesenchymal transition.

Xiao L, Dudley AC.

J Pathol. 2017 Jan;241(1):25-35. doi: 10.1002/path.4814. Epub 2016 Nov 10. Review.

PMID:
27701751
3.

Isolation and Culture Expansion of Tumor-specific Endothelial Cells.

Xiao L, McCann JV, Dudley AC.

J Vis Exp. 2015 Oct 14;(105):e53072. doi: 10.3791/53072.

4.

TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation.

Thoppil RJ, Adapala RK, Cappelli HC, Kondeti V, Dudley AC, Gary Meszaros J, Paruchuri S, Thodeti CK.

Sci Rep. 2015 Sep 21;5:14257. doi: 10.1038/srep14257.

5.

Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy.

Adapala RK, Thoppil RJ, Ghosh K, Cappelli HC, Dudley AC, Paruchuri S, Keshamouni V, Klagsbrun M, Meszaros JG, Chilian WM, Ingber DE, Thodeti CK.

Oncogene. 2016 Jan 21;35(3):314-22. doi: 10.1038/onc.2015.83. Epub 2015 Apr 13.

6.

Feeding cancer's sweet tooth: specialized tumour vasculature shuttles glucose in pancreatic ductal adenocarcinoma.

Dudley AC, Bautch VL.

J Pathol. 2015 Jun;236(2):133-5. doi: 10.1002/path.4526. Epub 2015 Mar 30.

7.

Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition.

Xiao L, Kim DJ, Davis CL, McCann JV, Dunleavey JM, Vanderlinden AK, Xu N, Pattenden SG, Frye SV, Xu X, Onaitis M, Monaghan-Benson E, Burridge K, Dudley AC.

Cancer Res. 2015 Apr 1;75(7):1244-54. doi: 10.1158/0008-5472.CAN-14-1616. Epub 2015 Jan 29.

8.

Vascular channels formed by subpopulations of PECAM1+ melanoma cells.

Dunleavey JM, Xiao L, Thompson J, Kim MM, Shields JM, Shelton SE, Irvin DM, Brings VE, Ollila DW, Brekken RA, Dayton PA, Melero-Martin JM, Dudley AC.

Nat Commun. 2014 Oct 22;5:5200. doi: 10.1038/ncomms6200.

9.

Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.

Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Nikolaishvili-Feinberg N, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC.

Clin Cancer Res. 2014 Dec 1;20(23):6083-95. doi: 10.1158/1078-0432.CCR-14-0493. Epub 2014 Sep 17.

10.

Excess centrosomes disrupt endothelial cell migration via centrosome scattering.

Kushner EJ, Ferro LS, Liu JY, Durrant JR, Rogers SL, Dudley AC, Bautch VL.

J Cell Biol. 2014 Jul 21;206(2):257-72. doi: 10.1083/jcb.201311013.

11.

Identification of a stable molecular signature in mammary tumor endothelial cells that persists in vitro.

Xiao L, Harrell JC, Perou CM, Dudley AC.

Angiogenesis. 2014 Jul;17(3):511-8. doi: 10.1007/s10456-013-9409-y. Epub 2013 Nov 21.

12.

Loss of adipocyte specification and necrosis augment tumor-associated inflammation.

Wagner M, Bjerkvig R, Wiig H, Dudley AC.

Adipocyte. 2013 Jul 1;2(3):176-83. doi: 10.4161/adip.24472. Epub 2013 Apr 19.

13.

Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis.

Harrell JC, Pfefferle AD, Zalles N, Prat A, Fan C, Khramtsov A, Olopade OI, Troester MA, Dudley AC, Perou CM.

Clin Exp Metastasis. 2014 Jan;31(1):33-45. doi: 10.1007/s10585-013-9607-4. Epub 2013 Aug 22.

14.

A three-party alliance in solid tumors: Adipocytes, macrophages and vascular endothelial cells.

Wagner M, Dudley AC.

Adipocyte. 2013 Apr 1;2(2):67-73. doi: 10.4161/adip.23016.

15.

Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, Bhowmick NA, Rubin MA, D'Souza-Schorey C, Freeman MR.

Am J Pathol. 2012 Nov;181(5):1573-84. doi: 10.1016/j.ajpath.2012.07.030. Epub 2012 Sep 27.

16.

Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy.

Dunleavey JM, Dudley AC.

Curr Angiogenes. 2012 Jun 1;1(2):133-138.

17.

Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis.

Wagner M, Bjerkvig R, Wiig H, Melero-Martin JM, Lin RZ, Klagsbrun M, Dudley AC.

Angiogenesis. 2012 Sep;15(3):481-95. doi: 10.1007/s10456-012-9276-y. Epub 2012 May 22.

18.

Tumor endothelial cells.

Dudley AC.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006536. doi: 10.1101/cshperspect.a006536. Review.

19.

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.

Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, Barnés CM, Mammoto A, Mammoto T, Luria A, Benny O, Chaponis DM, Dudley AC, Greene ER, Vergilio JA, Pietramaggiori G, Scherer-Pietramaggiori SS, Short SM, Seth M, Lih FB, Tomer KB, Yang J, Schwendener RA, Hammock BD, Falck JR, Manthati VL, Ingber DE, Kaipainen A, D'Amore PA, Kieran MW, Zeldin DC.

J Clin Invest. 2012 Jan;122(1):178-91. doi: 10.1172/JCI58128. Epub 2011 Dec 19.

20.

Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release.

Lin RZ, Dreyzin A, Aamodt K, Li D, Jaminet SC, Dudley AC, Melero-Martin JM.

Blood. 2011 Nov 17;118(20):5420-8. doi: 10.1182/blood-2011-08-372946. Epub 2011 Sep 21.

Supplemental Content

Loading ...
Support Center